Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 May 1;181(5):1683–1692. doi: 10.1084/jem.181.5.1683

Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen

PMCID: PMC2191990  PMID: 7722447

Abstract

A dominant gene carried in certain inbred mouse strains confers susceptibility to tumors induced by polyoma virus. This gene, designated Pyvs, was defined in crosses between the highly susceptible C3H/BiDa strain and the highly resistant but H-2k-identical C57BR/cdJ strain. The resistance of C57BR/cdJ mice is overcome by irradiation, indicating an immunological basis. In F1 x C57BR/cdJ backcross mice, tumor susceptibility cosegregates with Mtv-7, a mouse mammary tumor provirus carried by the C3H/BiDa strain. This suggests that Pyvs might encode the Mtv-7 superantigen (SAG) and abrogate polyoma tumor immunosurveillance through elimination of T cells bearing specific V beta domains. DNA typing of 110 backcross mice showed no evidence of recombination between Pyvs and Mtv-7. Strongly biased usage of V beta 6 by polyoma virus-specific CD8+ cytotoxic T lymphocytes in C57BR/cdJ mice implicates T cells bearing this Mtv-7 SAG-reactive V beta domain as critical anti-polyoma tumor effector cells in vivo. These results indicate identity between Pyvs and Mtv-7 sag, and demonstrate a novel mechanism of inherited susceptibility to virus-induced tumors based on effects of an endogenous superantigen on the host's T cell repertoire.

Full Text

The Full Text of this article is available as a PDF (980.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acha-Orbea H., Shakhov A. N., Scarpellino L., Kolb E., Müller V., Vessaz-Shaw A., Fuchs R., Blöchlinger K., Rollini P., Billotte J. Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus. Nature. 1991 Mar 21;350(6315):207–211. doi: 10.1038/350207a0. [DOI] [PubMed] [Google Scholar]
  2. Allison A. C., Monga J. N., Hammond V. Increased susceptibility to virus oncogenesis of congenitally thymus-deprived nude mice. Nature. 1974 Dec 20;252(5485):746–747. doi: 10.1038/252746a0. [DOI] [PubMed] [Google Scholar]
  3. Behlke M. A., Chou H. S., Huppi K., Loh D. Y. Murine T-cell receptor mutants with deletions of beta-chain variable region genes. Proc Natl Acad Sci U S A. 1986 Feb;83(3):767–771. doi: 10.1073/pnas.83.3.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beutner U., Frankel W. N., Cote M. S., Coffin J. M., Huber B. T. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5432–5436. doi: 10.1073/pnas.89.12.5432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Casanova J. L., Maryanski J. L. Antigen-selected T-cell receptor diversity and self-nonself homology. Immunol Today. 1993 Aug;14(8):391–394. doi: 10.1016/0167-5699(93)90140-G. [DOI] [PubMed] [Google Scholar]
  6. Choi Y., Kappler J. W., Marrack P. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. Nature. 1991 Mar 21;350(6315):203–207. doi: 10.1038/350203a0. [DOI] [PubMed] [Google Scholar]
  7. Choi Y., Marrack P., Kappler J. W. Structural analysis of a mouse mammary tumor virus superantigen. J Exp Med. 1992 Mar 1;175(3):847–852. doi: 10.1084/jem.175.3.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dawe C. J., Freund R., Mandel G., Ballmer-Hofer K., Talmage D. A., Benjamin T. L. Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol. 1987 May;127(2):243–261. [PMC free article] [PubMed] [Google Scholar]
  9. Dietrich W., Katz H., Lincoln S. E., Shin H. S., Friedman J., Dracopoli N. C., Lander E. S. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics. 1992 Jun;131(2):423–447. doi: 10.1093/genetics/131.2.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dyson P. J., Knight A. M., Fairchild S., Simpson E., Tomonari K. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes. Nature. 1991 Feb 7;349(6309):531–532. doi: 10.1038/349531a0. [DOI] [PubMed] [Google Scholar]
  11. Festenstein H. Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse. Transplant Rev. 1973;15:62–88. doi: 10.1111/j.1600-065x.1973.tb00111.x. [DOI] [PubMed] [Google Scholar]
  12. Foo-Phillips M., Kozak C. A., Principato M. A., Abe R. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells. J Immunol. 1992 Dec 1;149(11):3440–3447. [PubMed] [Google Scholar]
  13. Fowlkes B. J., Schwartz R. H., Pardoll D. M. Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage. Nature. 1988 Aug 18;334(6183):620–623. doi: 10.1038/334620a0. [DOI] [PubMed] [Google Scholar]
  14. Freund R., Dawe C. J., Carroll J. P., Benjamin T. L. Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene. Am J Pathol. 1992 Dec;141(6):1409–1425. [PMC free article] [PubMed] [Google Scholar]
  15. Freund R., Dubensky T., Bronson R., Sotnikov A., Carroll J., Benjamin T. Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host. Virology. 1992 Dec;191(2):724–731. doi: 10.1016/0042-6822(92)90248-n. [DOI] [PubMed] [Google Scholar]
  16. Freund R., Sotnikov A., Bronson R. T., Benjamin T. L. Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology. 1992 Dec;191(2):716–723. doi: 10.1016/0042-6822(92)90247-m. [DOI] [PubMed] [Google Scholar]
  17. Garcea R. L., Talmage D. A., Harmatz A., Freund R., Benjamin T. L. Separation of host range from transformation functions of the hr-t gene of polyomavirus. Virology. 1989 Feb;168(2):312–319. doi: 10.1016/0042-6822(89)90271-7. [DOI] [PubMed] [Google Scholar]
  18. Gollob K. J., Palmer E. Divergent viral superantigens delete V beta 5+ T lymphocytes. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5138–5141. doi: 10.1073/pnas.89.11.5138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Golovkina T. V., Chervonsky A., Dudley J. P., Ross S. R. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell. 1992 May 15;69(4):637–645. doi: 10.1016/0092-8674(92)90227-4. [DOI] [PubMed] [Google Scholar]
  20. Gooding L. R. Characterization of a progressive tumor from C3H fibroblasts transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk. J Immunol. 1982 Sep;129(3):1306–1312. [PubMed] [Google Scholar]
  21. Gooding L. R. Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: studies employing recombinants within the H-2 complex. J Immunol. 1979 Mar;122(3):1002–1008. [PubMed] [Google Scholar]
  22. Greene M. I., Perry L. L., Kinney-Thomas E., Benjamin T. L. Specific thymus-derived (T) cell recognition of papova virus-transformed cells. J Immunol. 1982 Feb;128(2):732–736. [PubMed] [Google Scholar]
  23. Held W., Waanders G. A., Shakhov A. N., Scarpellino L., Acha-Orbea H., MacDonald H. R. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell. 1993 Aug 13;74(3):529–540. doi: 10.1016/0092-8674(93)80054-i. [DOI] [PubMed] [Google Scholar]
  24. Hengartner H., Odermatt B., Schneider R., Schreyer M., Wälle G., MacDonald H. R., Zinkernagel R. M. Deletion of self-reactive T cells before entry into the thymus medulla. Nature. 1988 Nov 24;336(6197):388–390. doi: 10.1038/336388a0. [DOI] [PubMed] [Google Scholar]
  25. Ignatowicz L., Kappler J. W., Marrack P., Scherer M. T. Identification of two V beta 7-specific viral superantigens. J Immunol. 1994 Jan 1;152(1):65–71. [PubMed] [Google Scholar]
  26. Kappler J. W., Staerz U., White J., Marrack P. C. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature. 1988 Mar 3;332(6159):35–40. doi: 10.1038/332035a0. [DOI] [PubMed] [Google Scholar]
  27. Korman A. J., Bourgarel P., Meo T., Rieckhof G. E. The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J. 1992 May;11(5):1901–1905. doi: 10.1002/j.1460-2075.1992.tb05242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kozak C., Peters G., Pauley R., Morris V., Michalides R., Dudley J., Green M., Davisson M., Prakash O., Vaidya A. A standardized nomenclature for endogenous mouse mammary tumor viruses. J Virol. 1987 May;61(5):1651–1654. doi: 10.1128/jvi.61.5.1651-1654.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kuo W. L., Vilander L. R., Huang M., Peterson D. O. A transcriptionally defective long terminal repeat within an endogenous copy of mouse mammary tumor virus proviral DNA. J Virol. 1988 Jul;62(7):2394–2402. doi: 10.1128/jvi.62.7.2394-2402.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. LAW L. W., DAWE C. J. Influence of total body x-irradiation on tumor induction by parotid tumor agent in adult mice. Proc Soc Exp Biol Med. 1960 Nov;105:414–419. doi: 10.3181/00379727-105-26127. [DOI] [PubMed] [Google Scholar]
  31. Lathe R., Kieny M. P., Gerlinger P., Clertant P., Guizani I., Cuzin F., Chambon P. Tumour prevention and rejection with recombinant vaccinia. 1987 Apr 30-May 6Nature. 326(6116):878–880. doi: 10.1038/326878a0. [DOI] [PubMed] [Google Scholar]
  32. Law L. W. Immunologic responsiveness and the induction of experimental neoplasms. Cancer Res. 1966 Jun;26(6):1121–1134. [PubMed] [Google Scholar]
  33. Law L. W., Ting R. C., Leckband E. Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells. Proc Natl Acad Sci U S A. 1967 Apr;57(4):1068–1075. doi: 10.1073/pnas.57.4.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Litt M., Hauge X., Sharma V. Shadow bands seen when typing polymorphic dinucleotide repeats: some causes and cures. Biotechniques. 1993 Aug;15(2):280–284. [PubMed] [Google Scholar]
  35. Lukacher A. E., Freund R., Carroll J. P., Bronson R. T., Benjamin T. L. Pyvs: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus. Virology. 1993 Sep;196(1):241–248. doi: 10.1006/viro.1993.1472. [DOI] [PubMed] [Google Scholar]
  36. MacDonald H. R., Schneider R., Lees R. K., Howe R. C., Acha-Orbea H., Festenstein H., Zinkernagel R. M., Hengartner H. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature. 1988 Mar 3;332(6159):40–45. doi: 10.1038/332040a0. [DOI] [PubMed] [Google Scholar]
  37. McCormack J. E., Kappler J., Marrack P. Stimulation with specific antigen can block superantigen-mediated deletion of T cells in vivo. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2086–2090. doi: 10.1073/pnas.91.6.2086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Penn I. Tumors of the immunocompromised patient. Annu Rev Med. 1988;39:63–73. doi: 10.1146/annurev.me.39.020188.000431. [DOI] [PubMed] [Google Scholar]
  39. Pircher H., Bürki K., Lang R., Hengartner H., Zinkernagel R. M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 1989 Nov 30;342(6249):559–561. doi: 10.1038/342559a0. [DOI] [PubMed] [Google Scholar]
  40. Pullen A. M., Choi Y., Kushnir E., Kappler J., Marrack P. The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens. J Exp Med. 1992 Jan 1;175(1):41–47. doi: 10.1084/jem.175.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pullen A. M., Kappler J. W., Marrack P. Tolerance to self antigens shapes the T-cell repertoire. Immunol Rev. 1989 Feb;107:125–139. doi: 10.1111/j.1600-065x.1989.tb00006.x. [DOI] [PubMed] [Google Scholar]
  42. Pullen A. M., Marrack P., Kappler J. W. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature. 1988 Oct 27;335(6193):796–801. doi: 10.1038/335796a0. [DOI] [PubMed] [Google Scholar]
  43. Ramarathinam L., Castle M., Wu Y., Liu Y. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J Exp Med. 1994 Apr 1;179(4):1205–1214. doi: 10.1084/jem.179.4.1205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Raptis L., Lamfrom H., Benjamin T. L. Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibroblasts. Mol Cell Biol. 1985 Sep;5(9):2476–2486. doi: 10.1128/mcb.5.9.2476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Reinholdsson-Ljunggren G., Ramqvist T., Ahrlund-Richter L., Dalianis T. Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle- and large-T antigens. Int J Cancer. 1992 Jan 2;50(1):142–146. doi: 10.1002/ijc.2910500128. [DOI] [PubMed] [Google Scholar]
  46. Restifo N. P., Esquivel F., Kawakami Y., Yewdell J. W., Mulé J. J., Rosenberg S. A., Bennink J. R. Identification of human cancers deficient in antigen processing. J Exp Med. 1993 Feb 1;177(2):265–272. doi: 10.1084/jem.177.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Scherer M. T., Ignatowicz L., Winslow G. M., Kappler J. W., Marrack P. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol. 1993;9:101–128. doi: 10.1146/annurev.cb.09.110193.000533. [DOI] [PubMed] [Google Scholar]
  48. Shaper N. L., Shaper J. H., Peyser M., Kozak C. A. Localization of the gene for beta 1,4-galactosyltransferase to a position in the centromeric region of mouse chromosome 4. Cytogenet Cell Genet. 1990;54(3-4):172–174. doi: 10.1159/000132987. [DOI] [PubMed] [Google Scholar]
  49. Talmage D. A., Freund R., Dubensky T., Salcedo M., Gariglio P., Rangel L. M., Dawe C. J., Benjamin T. L. Heterogeneity in state and expression of viral DNA in polyoma virus-induced tumors of the mouse. Virology. 1992 Apr;187(2):734–747. doi: 10.1016/0042-6822(92)90476-6. [DOI] [PubMed] [Google Scholar]
  50. Talmage D. A., Freund R., Young A. T., Dahl J., Dawe C. J., Benjamin T. L. Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis. Cell. 1989 Oct 6;59(1):55–65. doi: 10.1016/0092-8674(89)90869-6. [DOI] [PubMed] [Google Scholar]
  51. Tanaka Y., Tevethia S. S. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones. J Immunol. 1988 Jun 15;140(12):4348–4354. [PubMed] [Google Scholar]
  52. Treisman R., Novak U., Favaloro J., Kamen R. Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature. 1981 Aug 13;292(5824):595–600. doi: 10.1038/292595a0. [DOI] [PubMed] [Google Scholar]
  53. Tsiagbe V. K., Asakawa J., Miranda A., Sutherland R. M., Paterson Y., Thorbecke G. J. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells. J Immunol. 1993 Jun 15;150(12):5519–5528. [PubMed] [Google Scholar]
  54. Tsiagbe V. K., Yoshimoto T., Asakawa J., Cho S. Y., Meruelo D., Thorbecke G. J. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J. 1993 Jun;12(6):2313–2320. doi: 10.1002/j.1460-2075.1993.tb05885.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Vasmel W. L., Sijts E. J., Leupers C. J., Matthews E. A., Melief C. J. Primary virus-induced lymphomas evade T cell immunity by failure to express viral antigens. J Exp Med. 1989 Apr 1;169(4):1233–1254. doi: 10.1084/jem.169.4.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Waanders G. A., McDonald H. R. Hierarchy of responsiveness in vivo and in vitro among T cells expressing distinct Mls-1a-reactive v beta domains. Eur J Immunol. 1992 Jan;22(1):291–293. doi: 10.1002/eji.1830220144. [DOI] [PubMed] [Google Scholar]
  57. Wallace V. A., Rahemtulla A., Timms E., Penninger J., Mak T. W. CD4 expression is differentially required for deletion of MLS-1a-reactive T cells. J Exp Med. 1992 Nov 1;176(5):1459–1463. doi: 10.1084/jem.176.5.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Woodland D. L., Happ M. P., Gollob K. J., Palmer E. An endogenous retrovirus mediating deletion of alpha beta T cells? Nature. 1991 Feb 7;349(6309):529–530. doi: 10.1038/349529a0. [DOI] [PubMed] [Google Scholar]
  59. Yazdanbakhsh K., Park C. G., Winslow G. M., Choi Y. Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor V beta specificity. J Exp Med. 1993 Aug 1;178(2):737–741. doi: 10.1084/jem.178.2.737. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES